Molecular & Cellular Proteomics · 2015 · 62 citations · 40 references
Life SciencesBiochemistryOncologyMolecular OncologyPost-translational ModificationProteomicsCancer BiomarkersCancer ProteomicsPeptide AnalysisPeptide IdentificationProteomic BiomarkersProteomic ProfilingImmunoaffinity PurificationPeptide Mass SpectrometryPlasma ProteomicsProtein Abundance ProfilingProtein Mass SpectrometryProteomic Biomarker DiscoveryQuantification Of Post-translational ModificationsQuantitative Biomarker Discovery
A robust method was developed and optimized for enrichment and quantitative analysis of posttranslational modifications (PTMs) in serum/plasma samples by combining immunoaffinity purification and LC-MS/MS without depletion of abundant proteins. The method was used to survey serum samples of patients with acute myeloid leukemia (AML), breast cancer (BC), and nonsmall cell lung cancer (NSCLC). Peptides were identified from serum samples containing phosphorylation, acetylation, lysine methylation, and arginine methylation. Of the PTMs identified, lysine acetylation (AcK) and arginine mono-methylation (Rme) were more prevalent than other PTMs. Label-free quantitative analysis of AcK and Rme peptides was performed for sera from AML, BC, and NSCLC patients. Several AcK and Rme sites showed distinct abundance distribution patterns across the three cancer types. The identification and quantification of posttranslationally modified peptides in serum samples reported here can be used for patient profiling and biomarker discovery research. A robust method was developed and optimized for enrichment and quantitative analysis of posttranslational modifications (PTMs) in serum/plasma samples by combining immunoaffinity purification and LC-MS/MS without depletion of abundant proteins. The method was used to survey serum samples of patients with acute myeloid leukemia (AML), breast cancer (BC), and nonsmall cell lung cancer (NSCLC). Peptides were identified from serum samples containing phosphorylation, acetylation, lysine methylation, and arginine methylation. Of the PTMs identified, lysine acetylation (AcK) and arginine mono-methylation (Rme) were more prevalent than other PTMs. Label-free quantitative analysis of AcK and Rme peptides was performed for sera from AML, BC, and NSCLC patients. Several AcK and Rme sites showed distinct abundance distribution patterns across the three cancer types. The identification and quantification of posttranslationally modified peptides in serum samples reported here can be used for patient profiling and biomarker discovery research. Biomarker identification is a key step for illustration of disease mechanisms, drug development, and diagnostics. Diagnostics research has focused on identifying biomarkers from viable biofluids, including serum/plasma, saliva, cerebrospinal fluid, and urine. Due to ease of collection and richness in proteins and metabolites, serum/plasma has been the preferred choice for diagnostic studies (1.Galasko D. Golde T.E. Biomarkers for Alzheimer's disease in plasma, serum and blood—Conceptual and practical problems.Alzheimer's Res. Therapy. 2013; 5: 10Crossref PubMed Scopus (49) Google Scholar, 2.Ahn J.M. Sung H.J. Yoon Y.H. Kim B.G. Yang W.S. Lee C. Park H.M. Kim B.J. Kim B.G. Lee S.Y. An H.J. Cho J.Y. Integrated glycoproteomics demonstrates fucosylated serum paraoxonase 1 alterations in small cell lung cancer.Mol. Cell. Proteomics. 2014; 13: 30-48Abstract Full Text Full Text PDF PubMed Scopus (76) Google Scholar, 3.Yotsukura S. Mamitsuka H. Evaluation of serum-based cancer biomarkers: A brief review from a clinical and computational viewpoint.Crit. Rev. Oncol. Hematol. 2015; 93: 103-115Crossref PubMed Scopus (38) Google Scholar). Advancement of mass-spectrometry-based proteomic technologies has allowed identification and quantification of thousands of proteins in serum/plasma samples. Typically, these methods combine isotopic labeling, offline fractionation, and LC-MS/MS analysis. Facilitated by high-throughput proteomics analysis, researchers have collected vast amounts of comparative information about protein abundance in serum/plasma of patients of various types of diseases that accelerated the identification of potential biomarkers (4.Keshishian H. Burgess M.W. Gillette M.A. Mertins P. Clauser K.R. Mani D.R. Kuhn E.W. Farrell L.A. Gerszten R.E. Carr S.A. Multiplexed, quantitative workflow for sensitive biomarker discovery in plasma yields novel candidates for early myocardial injury.Mol. Cell. Proteomics. 2015; 14: 2373-2393Abstract Full Text Full Text PDF Scopus (145) Google Scholar). To date, the majority of serum/plasma proteomic work has been conducted to analyze total protein level abundance, with only a few studies to analyze posttranslational modifications (PTMs) 1The abbreviations used are:PTMposttranslational modificationAMLacute myeloid leukemiaBCbreast cancerNSCLCnonsmall cell lung cancerAcKlysine acetylationRmearginine mono-methylationIMACimmobilized metal ion affinity chromatographyhnRNPheterogeneous nuclear ribonucleoprotein., usually glycosylation (5.Berven F.S. Ahmad R. Clauser K.R. Carr S.A. Optimizing performance of glycopeptide capture for plasma proteomics.J. Proteome Res. 2010; 9: 1706-1715Crossref PubMed Scopus (47) Google Scholar, 6.Chen S. Lu C. Gu H. Mehta A. Li J. Romano P.B. Horn D. Hooper D.C. Bazemore-Walker C.R. Block T. Aleuria aurantia lectin (AAL)-reactive immunoglobulin G rapidly appears in sera of animals following antigen exposure.PloS One. 2012; 7: e44422Crossref PubMed Scopus (13) Google Scholar). As one of the most important mechanisms for regulating protein function, PTMs, including phosphorylation, acetylation, ubiquitination, and methylation, have been identified and validated as critical for signaling transduction, protein degradation, and transcriptional regulation (7.Prabakaran S. Lippens G. Steen H. Gunawardena J. Post-translational modification: Nature's escape from genetic imprisonment and the basis for dynamic information encoding.Wiley Interdisciplinary Rev. Syst. Biol. Med. 2012; 4: 565-583Crossref PubMed Scopus (235) Google Scholar, 8.Huang H. Lin S. Garcia B.A. Zhao Y. Quantitative proteomic analysis of histone modifications.Chemical Rev. 2015; 115: 2376-2418Crossref PubMed Scopus (253) Google Scholar). Currently, there exists very limited data about PTMs in serum/plasma beyond glycosylation. The abundant serum protein albumin has long been known to be acetylated by aspirin, and this reaction can occur in vitro without the presence of any acetyltransferase (9.Liyasova M.S. Schopfer L.M. Lockridge O. Reaction of human albumin with aspirin in vitro: Mass spectrometric identification of acetylated lysines 199, 402, 519, and 545.Biochem. Pharmacol. 2010; 79: 784-791Crossref PubMed Scopus (65) Google Scholar). Fibrinogen, another abundant serum protein, is also acetylated by aspirin both in vivo and in vitro (10.Bjornsson T.D. Schneider D.E. Berger Jr., H. Aspirin acetylates fibrinogen and enhances fibrinolysis. Fibrinolytic effect is independent of changes in plasminogen activator levels.J. Pharmacol. Exp. Therapeut. 1989; 250: 154-161PubMed Google Scholar, 11.Pinckard R.N. Hawkins D. Farr R.S. In vitro acetylation of plasma proteins, enzymes and DNA by aspirin.Nature. 1968; 219: 68-69Crossref PubMed Scopus (156) Google Scholar). These previous findings and the known importance of PTMs in cellular signaling provided the impetus for a large-scale survey of PTMs other than glycosylation by immunoaffinity enrichment of PTM-containing peptides. posttranslational modification acute myeloid leukemia breast cancer nonsmall cell lung cancer lysine acetylation arginine mono-methylation immobilized metal ion affinity chromatography heterogeneous nuclear ribonucleoprotein. One challenge for proteomic analysis of serum/plasma is the broad dynamic range of the serum/plasma proteome P. 2010; PubMed Scopus Google including a of the total protein of serum/plasma by only proteins. can be by of abundant proteins to (4.Keshishian H. Burgess M.W. Gillette M.A. Mertins P. Clauser K.R. Mani D.R. Kuhn E.W. Farrell L.A. Gerszten R.E. Carr S.A. Multiplexed, quantitative workflow for sensitive biomarker discovery in plasma yields novel candidates for early myocardial injury.Mol. Cell. Proteomics. 2015; 14: 2373-2393Abstract Full Text Full Text PDF Scopus (145) Google Scholar, a human serum by with Cell. Proteomics. Full Text Full Text PDF PubMed Scopus Google of the of for enrichment with workflow be was of to a enrichment workflow from serum/plasma without the for depletion of the abundant proteins. method profiling from a of serum for by LC-MS/MS analysis. the PTMs lysine acetylation (AcK) and arginine mono-methylation (Rme) were identified as the more prevalent PTMs in cancer These PTMs were in sera from patients with acute leukemia (AML), breast cancer (BC), and nonsmall cell lung cancer (NSCLC). have identified AcK sites and Rme sites in the sera of cancer patients. The abundant serum protein human albumin was identified acetylated other abundant proteins were also to be including and of the identified AcK sites of were from the most abundant serum proteins. In the Rme sites identified were from a more of proteins, including transcriptional and proteins. Quantitative analysis identified a of peptides in enrichment with abundance across the three cancer types the abundance of a from the protein was in the sera of NSCLC patients with and patients. the abundance of from protein was in the sera of NSCLC than the other cancer types. of the quantitative data for the AcK and Rme patterns of modification to cancer as as patient these data the of profiling of human serum samples for disease and the potential for biomarker samples of patients of AML, BC, and NSCLC were from information and the of total protein of serum provided in samples were the method as A. Gu H. J. D. Y. Lee Yang J. J. S.A. enrichment and analysis of protein Cell. Proteomics. 2014; 13: Full Text Full Text PDF PubMed Scopus Google Scholar). of serum for were with 1 1 to a of the serum from nonsmall cell lung cancer patients were and three for independent The samples were for were collected and with for were with for in the were with and with were with and peptides were Peptides were with in and of posttranslationally modified peptides was performed the in following A. Gu H. J. D. Y. Lee Yang J. J. S.A. enrichment and analysis of protein Cell. Proteomics. 2014; 13: Full Text Full Text PDF PubMed Scopus Google Scholar, T. Gu H. Mertins P. J. S. Kuhn Carr S.A. quantitative of the lysine novel and optimized proteomic Cell. Proteomics. 2015; 14: Full Text Full Text PDF PubMed Scopus Google Scholar). amounts of the were to A serum peptides were in and were with for were by were three with containing and three with 1 and Peptides were from with of by peptides were with and with in peptides were and to a of in for to and any in the were with and as of posttranslationally modified peptides identified various from sera of cancer modified in a enrichment was performed as Y. G. for Cell. Proteomics. Full Text Full Text PDF PubMed Scopus Google Scholar). were with to the three with with for and were to from of serum in 1 for peptides were by three with peptides were with of for The was by and in a were in and in a peptides were in and on a a with was and were to the of and for of the A was in in a total of to LC-MS/MS analysis. peptides from serum were for peptides from serum were were to changes in abundance to changes in performance One of was the in Peptides were a of in from to were collected in a with a a dynamic of and a of The was with a of of was performed L.M. Li G. P. R. A. O. S. on a Cell. Proteomics. 4: Full Text Full Text PDF PubMed Scopus Google with a ion The data with this including in be from the with and were and the from An to data of peptides with in a protein Mass 5: PubMed Scopus Google Scholar, T. R. S.A. J. A of protein and 2010; Full Text Full Text PDF PubMed Scopus Google Scholar, J. S.A. S.A. analysis of PubMed Scopus Google Scholar). were the on containing and A of was used for and 1 for was limited to with one and to was as a of and the were allowed as modifications for enrichment were for to discovery and a in the of quantitative were and to the of the to M.S. C.R. and of proteomic data ion in to protein acetylation and Cell. Proteomics. 2012; Full Text Full Text PDF PubMed Scopus Google Scholar, A. H. A. analysis of and signaling by quantitative Cell. Proteomics. 2013; Full Text Full Text PDF PubMed Scopus Google Scholar). ion for that in abundance samples were to in analysis of the quantitative data was a cancer The from three was used to for abundance changes of a cancer discovery for was by the of the quantitative data were and in of serum samples were with and on and serum was and were serum was and were were to and for 1 in in and albumin were in in were three with with for 1 in and three with and developed on the were from To workflow for analysis of posttranslational modifications in serum enrichment various and with serum samples as in samples were for enrichment without any depletion of abundant serum proteins. The performed enrichment by enrichment arginine mono-methylation and lysine Of these and showed the most with the of peptides The of for the was and to known to be important disease for the cancer types the to PTMs from serum the immunoaffinity enrichment method to lysine acetylation and arginine mono-methylation in patient sera of acute myeloid leukemia (AML), breast cancer (BC), and nonsmall cell lung cancer for of samples As PTMs were enrichment was performed on the as P. J. Clauser K.R. Mani D.R. Burgess M.W. Gillette M.A. Carr S.A. Integrated proteomic analysis of modifications by 2013; PubMed Scopus Google Scholar). To from as and the only patients of The workflow of the enrichment is in to immunoaffinity and Rme were performed on the patient samples of the AcK in the a range to human albumin with other the In the Rme the from albumin was with other various for AcK a range of to AcK peptides from serum enrichment for Rme a range of to Rme peptides from serum and AcK and Rme sites identified were by peptides to and were by protein and the with the of in and as the for a In and sites were identified for AcK and Of AcK sites and Rme sites were and be the as a J.M. A to protein 4: PubMed Scopus Google Scholar). identified and proteins from AcK and Rme The protein in enrichment in the in (AcK) and AcK the protein were protein, protein, protein, protein, and transcriptional Peptides from albumin were identified acetylated a total of AcK is with the in of acetylation sites were also identified on other proteins, including and with a total of and AcK sites identified, about of AcK sites identified of were from the abundant serum proteins. for only of Rme sites from abundant serum proteins were The protein for Rme were protein, transcriptional protein, and A of Rme sites was identified from various heterogeneous nuclear most of have been identified in a previous A. Gu H. J. D. Y. Lee Yang J. J. S.A. enrichment and analysis of protein Cell. Proteomics. 2014; 13: Full Text Full Text PDF PubMed Scopus Google Scholar). The presence of these posttranslationally modified peptides in serum/plasma has been The data for the were with only proteins identified in was also a of these and a large-scale plasma proteome and offline to LC-MS/MS analysis, identified proteins with (4.Keshishian H. Burgess M.W. Gillette M.A. Mertins P. Clauser K.R. Mani D.R. Kuhn E.W. Farrell L.A. Gerszten R.E. Carr S.A. Multiplexed, quantitative workflow for sensitive biomarker discovery in plasma yields novel candidates for early myocardial injury.Mol. Cell. Proteomics. 2015; 14: 2373-2393Abstract Full Text Full Text PDF Scopus (145) Google with of proteins in for AcK and of for Rme A of NSCLC patient serum was three and to independent for AcK and and LC-MS/MS analysis. have identified and AcK peptides and and Rme peptides from the three independent A total of AcK peptides and Rme peptides were identified across the of AcK and Rme were by three samples Of the peptides identified, AcK and Rme were the quantification and The of for the PTMs in The were and for lysine acetylation and arginine of peptides and of peptides than of the method A quantification was to analyze abundance changes across the three cancer types of were to for identification of peptides and to data on of the To the of the and a of peptides from proteins was to to of the proteins were to the human to identification of these peptides in LC-MS/MS peptides with the range were to and across LC-MS/MS were performance of the the analysis. and were used for the quantification of posttranslationally modified peptides across samples. across LC-MS/MS by ion that a and can be to ion M.S. C.R. and of proteomic data ion in to protein acetylation and Cell. Proteomics. 2012; Full Text Full Text PDF PubMed Scopus Google Scholar). of across samples a was identified in A. Gu H. J. D. Y. Lee Yang J. J. S.A. enrichment and analysis of protein Cell. Proteomics. 2014; 13: Full Text Full Text PDF PubMed Scopus Google Scholar, M.S. C.R. and of proteomic data ion in to protein acetylation and Cell. Proteomics. 2012; Full Text Full Text PDF PubMed Scopus Google Scholar, A. A. C. P. J. and of Cell. Proteomics. 2015; 14: Full Text Full Text PDF PubMed Scopus Google Scholar). important for quantification of and of the ion both of were in In have and sites for AcK and of and The was for AcK of across and for Rme of across samples. the distribution of for AcK and Rme data in The changes of across three cancer types were by the of the modified across patients of cancer analysis of was performed a of and sites with any than than and a than were in and with in the of and in the patient samples were with the across samples to were used to in and Rme samples from the cancer with breast cancer and acute myeloid leukemia than with nonsmall cell lung cancer AcK patients of the of cancer were in the patients and of nonsmall cell lung cancer were patient was that a of abundance for most AcK sites with the of Rme the breast cancer and acute myeloid leukemia is than with nonsmall cell lung of abundance cancer types a acetylated was and in NSCLC samples than the in breast cancer and An from the protein was identified and abundance was and in NSCLC samples than the in breast cancer and peptides showed the cancer as a acetylated of albumin was of abundance in NSCLC patients and with and with the other cancer NSCLC patient showed to breast cancer and samples there were in abundance for acetylated peptides from the protein level of albumin was The of NSCLC patient of was cell the of and patients of NSCLC was and of of and A of AcK sites showed in patient of the NSCLC cell with patients as of The abundance of the is in the than the the total protein abundance of human albumin showed changes by has been on method for the serum/plasma proteome to potential biomarkers (1.Galasko D. Golde T.E. Biomarkers for Alzheimer's disease in plasma, serum and blood—Conceptual and practical problems.Alzheimer's Res. Therapy. 2013; 5: 10Crossref PubMed Scopus (49) Google Scholar, 3.Yotsukura S. Mamitsuka H. Evaluation of serum-based cancer biomarkers: A brief review from a clinical and computational viewpoint.Crit. Rev. Oncol. Hematol. 2015; 93: 103-115Crossref PubMed Scopus (38) Google Scholar, serum protein biomarker by and in breast Res. 2014; PubMed Scopus Google Scholar, Jr., of serum biomarkers for the of lung Oncol. PubMed Scopus Google Scholar). In the have developed a robust workflow combining enrichment and LC-MS/MS analysis for profiling PTMs. The workflow has to analyze both plasma and serum samples for PTMs, including phosphorylation, acetylation, arginine methylation, and lysine methylation, with lysine acetylation and arginine mono-methylation the of important of the workflow is with both and quantification this quantification on for identified A. Gu H. J. D. Y. Lee Yang J. J. S.A. enrichment and analysis of protein Cell. Proteomics. 2014; 13: Full Text Full Text PDF PubMed Scopus Google Scholar, A. H. A. analysis of and signaling by quantitative Cell. Proteomics. 2013; Full Text Full Text PDF PubMed Scopus Google Scholar). The key for quantification is the of performance the data collection To the of the have performed a NSCLC the identification of AcK and of Rme of peptides were identified across three LC-MS/MS The of identified modified peptides showed a distribution of across samples with the for AcK and Rme peptides were and and These quantitative data the of the method as as the of quantification for peptides with PTMs. These data with previous studies the of and quantification by affinity purification has been for changes of various PTMs A. Gu H. J. D. Y. Lee Yang J. J. S.A. enrichment and analysis of protein Cell. Proteomics. 2014; 13: Full Text Full Text PDF PubMed Scopus Google Scholar, M.S. C.R. and of proteomic data ion in to protein acetylation and Cell. Proteomics. 2012; Full Text Full Text PDF PubMed Scopus Google Scholar, S. C. J. human a distinct of and 2014; Full Text Full Text PDF PubMed Scopus Google Scholar, A. Lee A. and quantification of peptides from critical signaling proteins by immunoaffinity enrichment with Cell. Proteomics. 2012; Full Text Full Text PDF PubMed Scopus Google Scholar, Sung J.Y. Label-free quantitative proteomics and analysis of human Cell. Proteomics. 2012; Full Text Full Text PDF PubMed Scopus Google Scholar, P. enrichment by and of with and Cell. Proteomics. 2014; 13: Full Text Full Text PDF PubMed Scopus Google Scholar, J.M. Li C.R. Label-free quantitative proteomics of the lysine in of in 2013; PubMed Scopus Google Scholar, Yang signaling in a Biol. 2014; PubMed Scopus Google Scholar). both and have been developed for quantitative including and These have been and validated in the A. A. C. P. J. and of Cell. Proteomics. 2015; 14: Full Text Full Text PDF PubMed Scopus Google Scholar, J. quantification by and Cell. Proteomics. 2014; 13: Full Text Full Text PDF PubMed Scopus Google Scholar, Y.H. J.Y. Sung for analysis and data Cell. Proteomics. 2010; 9: Full Text Full Text PDF PubMed Scopus Google Scholar, H. S. J. A. H. O. R. An for high-throughput quantitative proteomics.J. Proteome Res. 2013; PubMed Scopus Google Scholar). data from the peptides showed and across LC-MS/MS that a of The of the quantitative data was also by review of for peptides with abundance changes across cancer The quantitative data from this showed a distinct for both AcK and Rme in NSCLC patient samples were than and The on the quantitative data also identified patient of NSCLC as in the for both was as the other three NSCLC patients were as cell the that serum PTMs also as biomarkers for of The small of samples for cancer in this on this as of be that this is in and work on a of samples be to more disease biomarkers identified In to proteome of serum/plasma, studies have of abundant proteins by offline to LC-MS/MS analysis (4.Keshishian H. Burgess M.W. Gillette M.A. Mertins P. Clauser K.R. Mani D.R. Kuhn E.W. Farrell L.A. Gerszten R.E. Carr S.A. Multiplexed, quantitative workflow for sensitive biomarker discovery in plasma yields novel candidates for early myocardial injury.Mol. Cell. Proteomics. 2015; 14: 2373-2393Abstract Full Text Full Text PDF Scopus (145) Google Scholar, A. Y. O. T. The of a serum proteome analysis for the discovery and identification of novel biomarkers of J. Proteomics. 2012; PubMed Google Scholar). with isotopic labeling, identified proteins from plasma samples of patients (4.Keshishian H. Burgess M.W. Gillette M.A. Mertins P. Clauser K.R. Mani D.R. Kuhn E.W. Farrell L.A. Gerszten R.E. Carr S.A. Multiplexed, quantitative workflow for sensitive biomarker discovery in plasma yields novel candidates for early myocardial injury.Mol. Cell. Proteomics. 2015; 14: 2373-2393Abstract Full Text Full Text PDF Scopus (145) Google Scholar). In the identified a total of proteins by combining the of both AcK and Rme Of there were proteins the studies be that peptides were for protein identification in the by in this reported proteins with one modified that also with identified plasma proteins in the Proteome A. A. R. Ahmad A. S. R. S. D. R. S. R. R. A. A. Proteome as a for proteomics Res. 2014; PubMed Scopus Google Scholar). of the proteins identified in of from the the of the the protein level is to the enrichment by that a of abundance proteins, including transcriptional proteins, and in the AcK enrichment identified proteins, including and and most were acetylated lysine have patterns of acetylation in NSCLC patients and of for these proteins with the NSCLC patient of cell The protein abundance of acetylated peptides in NSCLC with lysine acetylation sites patterns as by The abundance of acetylated albumin peptides was in to the total protein level of showed changes across cancer patients As the most abundant protein in albumin been as protein than a potential biomarker serum/plasma proteome profiling the findings in this of acetylation sites on albumin as and in cancer types that the potential exists for biomarker discovery abundant serum proteins. proteins, including and were identified in the acetylated a of lysine of histone is to the of these and and and the of DNA to various proteins S.Y. J.M. Rev. PubMed Scopus Google Scholar, R. S.Y. and PubMed Scopus Google Scholar, and to Biol. 5: PubMed Scopus Google Scholar). Peptides from histone acetylated and showed abundance cancer that as of the of In to the lysine acetylation in peptides were identified from abundant serum proteins, arginine peptides identified were protein with few to abundant serum proteins. The abundance of Rme sites were also than AcK sites the NSCLC and the other cancer there were as changes of Rme sites across the three cancer the patients to cancer more cancer and arginine mono-methylation in serum than lysine acetylation with the a and as cancer of the from quantitative data for and samples critical analysis of arginine mono-methylation and in abundance NSCLC serum samples with BC, including heterogeneous nuclear proteins in modification of Y.H. R. of the and J. 2010; PubMed Scopus Google Scholar). of containing the the J. B.J. The in Res. PubMed Scopus (145) Google Scholar). changes in the of identified arginine level in as of of of and of as as regulation in have been few studies that posttranslational modification of serum/plasma proteins, was the acetylation and arginine identified from was by in have identified lysine acetylation sites on including and is by the presence of types of histone as as in the nuclear proteins S. S. D.E. the human plasma proteome by Mass PubMed Scopus Google Scholar, T. A. plasma as a potential for cancer 2010; PubMed Scopus Google Scholar, Lee Cho J.Y. Lee H.J. Cho S.Y. and of the plasma 2010; PubMed Scopus Google Scholar). of albumin and by aspirin has been in one for lysine acetylation of proteins J. C. S. P. J. of of albumin and by acetylation in vitro and in Med. Google Scholar). The identification of most arginine sites on abundance proteins as transcriptional and proteins in that there was a reaction for in In protein arginine have been identified in plasma in previous studies S. S. D.E. the human plasma proteome by Mass PubMed Scopus Google Scholar, J. analysis of human serum Proteome Res. PubMed Scopus Google Scholar). arginine occur in by to the be in the In have a large-scale profiling in serum that identified types of PTMs in To this is the that identified and PTMs in The workflow have developed and optimized provided quantitative information for lysine acetylation and arginine mono-methylation in the serum samples of three cancer types. The identification of Rme modification of abundance proteins the and of enrichment for serum samples. In the identification of lysine acetylation sites in abundant serum proteins as of showed abundance patterns across cancer that of abundant proteins in serum is and for serum profiling these novel identification data of posttranslational modifications of serum proteins and a workflow that is for large-scale quantitative proteomic studies of clinical serum/plasma samples for biomarker with
40
Jürgen Cox, Marco Y. Hein, Christian A. Luber et al. · Molecular & Cellular Proteomics · 2014 · 5.5K citations · Full text
A Tissue-Specific Atlas of Mouse Protein Phosphorylation and Expression
Edward L. Huttlin, Mark P. Jedrychowski, Joshua E. Elias et al. · Cell · 2010 · 1.8K citations · Full text